GKOS

163.75

0.36% 0.58

Dopo l'orario di chiusura: 163.75

Glaukos Corp (GKOS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$163.17

Aprire:

$167.57

Volume 24 ore:

706.26K

Relative Volume:

0.89

Capitalizzazione di mercato:

$9.66B

Reddito:

$551.35M

Utile/perdita netta:

$-189.33M

Rapporto P/E:

-49.75

EPS:

-3.2916

Flusso di cassa netto:

$-35.09M

1 W Prestazione:

+6.04%

1M Prestazione:

-8.79%

6M Prestazione:

+45.21%

1 anno Prestazione:

+93.81%

Intervallo 1D:

$163.01

$168.08

Intervallo di 1 settimana:

$151.71

$168.73

Portata 52W:

$73.16

$191.62

Glaukos Corp Stock (GKOS) Company Profile

Nome

Glaukos Corp

Settore

Healthcare (1064)

Industria

Medical Devices (138)

Telefono

949-367-9600

Indirizzo

1 GLAUKOS WAY, ALISO VIEJO, CA

Dipendente

1,094

Cinguettio

@GlaukosCorp

Prossima data di guadagno

2026-11-04

Ultimi documenti SEC

GKOS's Discussions on Twitter

Compare GKOS vs ABT, MDT, SYK, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GKOS Glaukos Corp	163.75	9.11B	551.35M	-189.33M	-35.09M	-3.2916
ABT Abbott Laboratories	97.50	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	86.38	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	275.43	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	42.60	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.15	49.74B	6.30B	1.07B	1.09B	1.8406

Glaukos Corp Stock (GKOS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-07-06	Iniziato	H.C. Wainwright	Buy
2025-10-27	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2025-10-01	Iniziato	Goldman	Buy
2025-05-01	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-02-19	Aggiornamento	Mizuho	Neutral → Outperform
2024-12-11	Aggiornamento	Citigroup	Neutral → Buy
2024-12-06	Iniziato	UBS	Buy
2024-12-02	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2024-07-10	Downgrade	Citigroup	Buy → Neutral
2024-05-06	Aggiornamento	Jefferies	Hold → Buy
2023-12-21	Aggiornamento	JP Morgan	Neutral → Overweight
2023-12-04	Iniziato	Morgan Stanley	Equal-Weight
2023-11-28	Iniziato	Truist	Buy
2023-11-08	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-06-07	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-12-22	Iniziato	Mizuho	Neutral
2022-12-19	Aggiornamento	JP Morgan	Underweight → Neutral
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-10-14	Ripresa	Stephens	Overweight
2022-10-04	Iniziato	Needham	Buy
2022-07-12	Aggiornamento	Stifel	Hold → Buy
2022-02-03	Aggiornamento	William Blair	Mkt Perform → Outperform
2022-01-19	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-01-18	Aggiornamento	BTIG Research	Neutral → Buy
2021-11-03	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-07-26	Downgrade	Stephens	Overweight → Equal-Weight
2021-07-20	Downgrade	Wells Fargo	Equal Weight → Underweight
2021-07-14	Downgrade	Oppenheimer	Outperform → Perform
2021-07-14	Downgrade	William Blair	Outperform → Mkt Perform
2021-04-08	Aggiornamento	Oppenheimer	Perform → Outperform
2021-01-29	Downgrade	Piper Sandler	Overweight → Neutral
2020-12-16	Aggiornamento	Citigroup	Sell → Neutral
2020-12-09	Iniziato	Oppenheimer	Perform
2020-11-17	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2020-10-08	Downgrade	JP Morgan	Neutral → Underweight
2020-06-15	Iniziato	Jefferies	Hold
2020-03-05	Iniziato	Citigroup	Sell
2020-02-28	Downgrade	JP Morgan	Overweight → Neutral
2020-01-06	Aggiornamento	Berenberg	Hold → Buy
2019-12-12	Downgrade	Wells Fargo	Outperform → Underperform
2019-09-30	Downgrade	BofA/Merrill	Buy → Underperform
2019-03-08	Iniziato	BTIG Research	Neutral
2018-08-30	Iniziato	Berenberg	Hold
2018-08-29	Aggiornamento	JP Morgan	Neutral → Overweight
2018-08-03	Reiterato	Stifel	Hold
2018-06-21	Downgrade	JP Morgan	Overweight → Neutral
2018-04-13	Downgrade	Stifel	Buy → Hold
2018-03-01	Reiterato	Cantor Fitzgerald	Buy
2017-03-02	Reiterato	Cantor Fitzgerald	Overweight
2017-01-06	Aggiornamento	Stifel	Hold → Buy
2016-10-27	Iniziato	Wells Fargo	Outperform

Mostra tutto

Glaukos Corp Borsa (GKOS) Ultime notizie

Oct 01, 2026

Glaukos chief development officer sells $249k in stock By Investing.com - Investing.com Nigeria

Sep 28, 2026

Glaukos (GKOS) officer sells shares under a preset plan at weighted-average prices from $151.70 to $154.88 - Stock Titan

Sep 28, 2026

Glaukos options activity points to bullish call spread targeting $180 - Investing.com

Sep 28, 2026

Sep 26, 2026

Form 144 GLAUKOS Corp For: 26 September By Investing.com - Investing.com Nigeria

Sep 26, 2026

Sep 25, 2026

A Glaukos (NYSE: GKOS) officer proposes selling 1,615 shares on September 25. - Stock Titan

Sep 25, 2026

Sep 24, 2026

Presbyopia Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | AbbVie, Orasis Pharma, Eyenovia, Glaukos Corp., Ocuphire Pharma, Novartis - Barchart.com

Sep 24, 2026

Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now - Yahoo Finance

Sep 24, 2026

Glaukos Partners with NBA Champion Stephen Curry to Launch “Could - The National Law Review

Sep 24, 2026

Zacks Investment Research - גלובס

Sep 24, 2026

Sep 23, 2026

A Look at Glaukos Corp (GKOS) After 4.0% Decline -- GF Value $15 - GuruFocus

Sep 23, 2026

Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $210 - moomoo.com

Sep 23, 2026

$1000 Invested In Glaukos 10 Years Ago Would Be Worth This Much Today - Benzinga

Sep 23, 2026

Glaukos Partners with NBA Champion Stephen Curry to Launch "Could it be KC?" Campaign to Raise Awareness of Keratoconus - Yahoo Finance

Sep 23, 2026

Glaukos (GKOS), Why Is It Back In The Spotlight? - Yahoo Finance

Sep 23, 2026

Glaukos Corporation (GKOS) Options ChainYahoo Finance - Yahoo! Finance Canada

Sep 23, 2026

Sep 22, 2026

GKOS Maintained by Jefferies -- Price Target Raised to $210 - GuruFocus

Sep 22, 2026

Sep 20, 2026

Glaukos stock gains institutional support as Bank of America builds position - AD HOC NEWS

Sep 20, 2026

Sep 19, 2026

Glaukos chief development officer Tomas Navratil sells $243k in shares - Investing.com India

Sep 19, 2026

Sep 16, 2026